In parallel, King and colleagues demonstrated that transgenic TMPRSS2-ERG mice develop prostatic intraepithelial neoplasia (PIN) only in the context of PI3-kinase pathway activation when PTEN is inhibited or genetically ablated. The gene discussed is PTEN; the disease is prostate intraepithelial neoplasia.